Skip to Main Content

POGO's Staff Scientist Says New Doctor Rules Promote Transparency

New disclosure rules for doctors on advisory panels for the Food and Drug Administration are meant to increase transparency without discouraging doctors from serving on the panels, according to Ned Feder, the Project On Government Oversight's staff scientist. Feder was on Public News Service to discuss new rules for drug companies and medical device makers as part of the Affordable Care Act. \

According to Feder, increased transparency should help identify conflicts of interest among doctors who have a financial stake in drugs or devices they evaluate. 

It's hard to imagine that a person receiving this kind of payment will maintain complete objectivity over the value of the drug, its safety and its effectiveness.

You can listen to the segment by clicking here.

By: Andre Francisco
Online Producer, POGO

andre francisco Andre Francisco is the Online Producer for the Project On Government Oversight.

Topics: Public Health and Science

Related Content: Conflicts of Interest, Federal Advisory Committees, Food and Drug Administration (FDA), Integrity in Science, Medical Devices, Public Health, Science Policy

Authors: Andre Francisco

Submitted by Paul at: February 27, 2014
Thanks for accepting the comment. Off-course without my website's link :)
Submitted by Paul at: February 22, 2014
For smooth running of any Industry transparency is most important factor. Disclosure norms definitely helps in providing affordable care to the public. Casa Real

Leave A Comment

Nickname
Comment
Enter this word: Change

Related Posts

Browse POGOBlog by Topic

POGO on Facebook

POGOBlog Contributors

See All Blog Contributors

Latest Podcast

Podcast: Exploring Transparency for Oil and Gas Extraction

Mia Steinle talks about POGO's involvement in the Extractive Industries Transparency Initiative (EITI) and the hurdles to increased transparency for oil, gas and hard rock minerals here in the U.S.